Universal Germline Testing IDs Hereditary Risk in Late-Onset Tumors

THURSDAY, Oct. 15, 2026 -- Universal germline testing identifies pathogenic variants in patients with early-, average-, and late-onset cancer across 32 solid tumor types, according to a study published online Oct. 8 in Cancer Discovery.
Zsofia K...